"Fatty Acids, Omega-3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of unsaturated fatty acids occurring mainly in fish oils, with three double bonds at particular positions in the hydrocarbon chain.
| Descriptor ID |
D015525
|
| MeSH Number(s) |
D10.212.302.380.410 D10.251.355.337 D10.627.430.450
|
| Concept/Terms |
Fatty Acids, Omega-3- Fatty Acids, Omega-3
- n-3 Fatty Acids
- n 3 Fatty Acids
- n-3 Polyunsaturated Fatty Acid
- n 3 Polyunsaturated Fatty Acid
- n-3 PUFA
- PUFA, n-3
- n 3 PUFA
- Omega 3 Fatty Acids
- n3 PUFA
- PUFA, n3
- n3 Polyunsaturated Fatty Acid
- n3 Oils
- n-3 Oils
- n 3 Oils
- Omega-3 Fatty Acids
- n3 Fatty Acid
- Fatty Acid, n3
|
Below are MeSH descriptors whose meaning is more general than "Fatty Acids, Omega-3".
Below are MeSH descriptors whose meaning is more specific than "Fatty Acids, Omega-3".
This graph shows the total number of publications written about "Fatty Acids, Omega-3" by people in this website by year, and whether "Fatty Acids, Omega-3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 4 | 0 | 4 |
| 2014 | 2 | 2 | 4 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 0 | 3 |
| 2017 | 2 | 0 | 2 |
| 2018 | 5 | 0 | 5 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fatty Acids, Omega-3" by people in Profiles.
-
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis. Chest. 2024 Mar; 165(3):621-631.
-
Structural basis of omega-3 fatty acid transport across the blood-brain barrier. Nature. 2021 07; 595(7866):315-319.
-
Omega-3 Use for the Treatment of Hypertriglyceridemia, Low High-Density Lipoprotein Cholesterol Levels, and Nonalcoholic Fatty Liver Disease in Children with Obesity. Child Obes. 2021 07; 17(5):357-364.
-
The clinical black, white, and gray lessons. Curr Opin Lipidol. 2021 04 01; 32(2):151-156.
-
Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study. Lipids Health Dis. 2020 May 30; 19(1):117.
-
Omega-3 and hemocompatibility-related adverse events. J Card Surg. 2020 Feb; 35(2):405-412.
-
Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 10; 11(10):e005082.
-
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial. Clin Cardiol. 2018 Oct; 41(10):1281-1288.
-
Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovasc Diabetol. 2018 07 07; 17(1):98.
-
Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia. Cardiol Clin. 2018 May; 36(2):277-285.